Baptist Health Recalls Deferoxamine Cassettes Due to Sterility Concerns
Baptist Health Medical Towers Pharmacy is recalling five Deferoxamine cassettes in Arkansas due to a lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. According to the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects, are rated as Severe (4). While no specific injuries are reported in the text, the lack of sterility assurance in a subcutaneous product poses a significant risk of infection, aligning with the Severe classification for Class II recalls with potential for serious harm.
Plain-English summary
Baptist Health Medical Towers Pharmacy and Infusion Services in Little Rock, Arkansas, is recalling five cassettes of Deferoxamine 2 grams/51 mL NS. The product is intended for subcutaneous use only. The recall was initiated because of a lack of sterility assurance.
The affected product was distributed in Arkansas. The recall covers all product remaining within its expiry date. No specific lot numbers or dates are provided in the source text.
Consumers and healthcare providers should stop using the recalled cassettes and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- Deferoxamine 2 grams/51 mL NS cassette, FOR SUBCUTANEOUS USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR
- Category
- Drug — Injectable Medication
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All product remaining within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 38 recalled by Baptist Health Medical Towers Pharmacy and Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 38 products in this recall →Related recalls
Same manufacturer · Baptist Health Medical Towers Pharmacy and Infusion Services
See all →- HighBaptist Health Recalls Milrinone IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SevereBaptist Health Pharmacy Recalls 1/2 Normal Saline Bags for Sterility Concerns
FDA (Drugs) · 2016-06-08
- HighBaptist Health Recalls Deferoxamine Cassettes Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SevereBaptist Health Recalls Vancomycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- HighBaptist Health Recalls Four Bags of Piperacillin-Tazobactam Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
Same hazard · infection
See all →- SevereSafeguard US Operating LLC Recalls Compression Bandages Due to Degradation
FDA (Devices) · 2026-10-14
- SevereStryker Bard EP XT Decapolar Steerable Diagnostic EP Catheter Recalled for Sterile Barrier Breach
FDA (Devices) · 2026-10-14
- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
Similar recalls
- SevereLincare Recalls Deferoxamine Mesylate IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Ceftazidime IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Ceftriaxone Sodium Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- ModerateWalgreens Recalls Deferoxamine Infusions Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- SevereAmerita Recalls Baclofen Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-01-27
- SevereLincare Recalls Diphenhydramine Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-07-08